Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

I have been diagnosed with prostate cancer. My wife knows about it and has been very supportive, but we have not shared it ...

The Elekta Unity MR-LINAC system combines MRI imaging with radiation therapy to target cancerous cells with pinpoint ...